We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-2.13%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$850M
AUM Growth
+$2.81M
Cap. Flow
+$26.1M
Cap. Flow %
3.07%
Top 10 Hldgs %
59.06%
Holding
107
New
6
Increased
20
Reduced
2
Closed
10

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$18.8M
2
GE icon
GE Aerospace
GE
+$3.66M
3
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$2.86M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.45M
5
IBB icon
iShares Biotechnology ETF
IBB
+$2.36M

Top Sells

Rank Stock Value
1
POT
Potash Corp Of Saskatchewan
POT
+$19.4M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$614K
3
BIVV
Bioverativ Inc. Common Stock
BIVV
+$593K
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$377K
5
SGI
Somnigroup International
SGI
+$273K

Sector Composition

Rank Sector Weight
1 Financials 38.2%
2 Healthcare 24.47%
3 Industrials 10.98%
4 Technology 10.54%
5 Energy 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
51
McDonald's
MCD
$194B
$1.57M 0.19%
10,060
– –
PGNX
52
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.49M 0.18%
200,000
– –
CHL
53
DELISTED
China Mobile Limited
CHL
$1.36M 0.16%
+29,800
New +$1.45M
CBI
54
DELISTED
Chicago Bridge & Iron Nv
CBI
$1.34M 0.16%
93,000
– –
MO icon
55
Altria Group
MO
$109B
$1.32M 0.16%
+21,200
New +$1.4M
UTHR icon
56
United Therapeutics
UTHR
$22.1B
$1.29M 0.15%
11,490
– –
AKTX
57
Akari Therapeutics
AKTX
$13.5M
$1.16M 0.14%
795
+606
+321% +$1.31M
BDSI
58
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.13M 0.13%
500,000
-101,285
-17% -$237K
BUD icon
59
AB InBev
BUD
$159B
$1.11M 0.13%
10,100
– –
ST icon
60
Sensata Technologies
ST
$6.73B
$933K 0.11%
+18,000
New +$960K
STOR
61
DELISTED
STORE Capital Corporation
STOR
$911K 0.11%
36,700
– –
ACAD icon
62
Acadia Pharmaceuticals
ACAD
$5.07B
$899K 0.11%
40,000
– –
AMAG
63
DELISTED
AMAG Pharmaceuticals
AMAG
$880K 0.1%
43,691
-36,309
-45% -$614K
ALDX icon
64
Aldeyra Therapeutics
ALDX
$91.1M
$809K 0.1%
107,858
– –
SYNT
65
DELISTED
Syntel Inc
SYNT
$798K 0.09%
31,270
– –
AKAO
66
DELISTED
Achaogen Inc
AKAO
$777K 0.09%
60,000
– –
ADMS
67
DELISTED
Adamas Pharmaceuticals
ADMS
$717K 0.08%
30,000
– –
DNOW icon
68
DNOW Inc
DNOW
$3.01B
$569K 0.07%
55,675
– –
OCUL icon
69
Ocular Therapeutix
OCUL
$2.14B
$521K 0.06%
80,011
– –
VWO icon
70
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$517K 0.06%
11,000
– –
L icon
71
Loews
L
$23.1B
$482K 0.06%
9,700
– –
MON
72
DELISTED
Monsanto Co
MON
$450K 0.05%
+3,860
New +$464K
OMC icon
73
Omnicom Group
OMC
$23.6B
$400K 0.05%
5,500
+1,300
+31% +$97.5K
CPRI icon
74
Capri Holdings
CPRI
$1.77B
$327K 0.04%
5,260
– –
USNA icon
75
Usana Health Sciences
USNA
$254M
$295K 0.03%
3,440
– –
1 2
3
4 5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q1 2018 Portfolio in Review

As of Q1 2018, Hikari Power held 107 positions worth $850M, up 0.33% from $847M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Hikari Power deployed $26.1M of net new capital in Q1 2018, opening 6 new positions and adding to 20 existing holdings. Its largest new stake was Nutrien: 376,360 shares worth $17.8M.

By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $614K trimmed.

  • Hikari Power's largest Q1 2018 buy was Nutrien: 376,360 shares worth $17.8M.
  • Hikari Power added most to GE Aerospace in Q1 2018, an estimated $3.66M increase.
  • Hikari Power's biggest Q1 2018 reduction was AMAG Pharmaceuticals, cutting an estimated $614K.
  • Hikari Power fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $19.4M.
  • Hikari Power's ten largest holdings make up 59% of its $850M portfolio in Q1 2018.
  • Hikari Power opened 6 new positions and closed 10 in Q1 2018.
  • Hikari Power's portfolio value rose 0.33% quarter-over-quarter to $850M.

Based on Hikari Power's 13F filing for Q1 2018, filed 14 May 2018.